Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.75 |
| ▸ | CA2 | P00918 | 2/20 | 0.75 |
| ▸ | CA4 | P22748 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | LSS | P48449 | 2/20 | 0.37 |
| ▸ | GLB1 | P16278 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4843233 | 0.98 | CA1 (0.72) | CA1CA2CA4CYP1A2DPP4 | |
| SCHEMBL4844470 | 0.98 | CA1 (0.72) | CA1CA2CA4CYP1A2DPP4 | |
| SCHEMBL4836267 | 0.95 | CA1 (0.68) | CA1CA2CA4CYP1A2DPP4 | |
| SCHEMBL14424441 | 0.95 | CA1 (0.68) | CA1CA2CA4CYP1A2DPP4 | |
| SCHEMBL8754576 | 0.93 | CA1 (0.72) | CA1CA2CA4CYP1A2LSS | |
| SCHEMBL8754572 | 0.93 | CA1 (0.72) | CA1CA2CA4CYP1A2LSS | |
| SCHEMBL5557539 | 0.93 | CA1 (0.72) | CA1CA2CA4CYP1A2LSS | |
| SCHEMBL9115707 | 0.91 | CA1 (0.69) | CA1CA2CA4CYP1A2LSS | |
| SCHEMBL7204623 | 0.91 | CA1 (0.69) | CA1CA2CA4CYP1A2LSS | |
| SCHEMBL11214013 | 0.91 | CA1 (0.69) | CA1CA2CA4CYP1A2LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023054999-A1 | METHOD FOR MANUFACTURING POLYALKYLENE CARBONATE RESIN | 주식회사 엘지화학 | 2023-04-06 | — | — | WO | claimed |
| WO-2023038406-A1 | DOUBLE METAL CYANIDE CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PREPARING POLYALKYLENE CARBONATE BY USING SAME CATALYST | 주식회사 엘지화학 | 2023-03-16 | — | — | WO | claimed |
| CN-118725938-B | Antiwear system for improved copper corrosion | 雅富顿化学公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-117534568-A | Continuous synthesis method of tert-butylcyclohexyl acetate | 浙江新化化工股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-115916142-A | Coupled terpene conjugates | 埃里格实验室公司 | 2023-04-04 | — | — | CN | disclosed |
| WO-2023038406-A1 | DOUBLE METAL CYANIDE CATALYST, METHOD FOR PRODUCING SAME, AND METHOD FOR PREPARING POLYALKYLENE CARBONATE BY USING SAME CATALYST | 주식회사 엘지화학 | 2023-03-16 | — | — | WO | disclosed |
| CN-114269888-A | Fragrance enhancing compositions | 阿尔门德拉私人有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-111108090-A | Fragrance precursor | 高砂香料工业株式会社 | 2020-05-05 | — | — | CN | disclosed |
| US-20190284152-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-09-19 | — | — | US | disclosed |
| US-10294210-B2 | Maleinated derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180111912-A1 | Maleinated Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2018-04-26 | — | — | US | disclosed |
| WO-1988003552-A2 | SULFUR-CONTAINING COMPOSITIONS, LUBRICANT, FUEL AND FUNCTIONAL FLUID COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1988-05-19 | — | — | WO | disclosed |
| WO-1987007638-A2 | PHOSPHOROUS- AND SULFUR-CONTAINING LUBRICANT AND FUNCTIONAL FLUID COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1987-12-17 | — | — | WO | disclosed |
| WO-1987007637-A2 | PHOSPHORUS-CONTAINING LUBRICANT AND FUNCTIONAL FLUID COMPOSITIONS | THE LUBRIZOL CORPORATION (US) | 1987-12-17 | — | — | WO | disclosed |
| EP-0042270-B1 | LUBRICATING OIL ADDITIVE, METHOD FOR MAKING THE SAME, LUBRICATING OIL ADDITIVE PACKAGE, AND LUBRICATING OIL COMPOSITION COMPRISING THE SAME, AND THE USE OF CERTAIN SUCCINIMIDES IN FORMING OIL ADDITIVES | EDWIN COOPER INC. (US) | 1984-09-12 | — | — | EP | disclosed |
| US-4374033-A | REACTION PRODUCT OF AN ALIPHATIC HYDROCARBON SUBSTITUTED SUCCINIC ANHYDRIDE, AMINO PYRROLIDONE AND A BORON COMPOUND | EDWIN COOPER, INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4295983-A | Lubricating oil composition containing boronated N-hydroxymethyl succinimide friction reducers | ETHYL CORPORATION (US) | 1981-10-20 | — | — | US | disclosed |
| US-4119552-A | DISPERSANT, AMIDATION OF PHENOXYALKANOIC ACID, REACTION OF THE AMIDE WITH A BORON COMPOUND | EDWIN COOPER AND COMPANY LIMITED (GB) | 1978-10-10 | — | — | US | disclosed |
| US-4034038-A | Boron-containing esters | THE LUBRIZOL CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
| US-3970705-A | COPPER HALIDE | THE B. F. GOODRICH COMPANY (US) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111912-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | CA1 402/4885CA2 760/4885CA4 930/4885 |
| US-20190284152-A1 | Maleinated Derivatives | SMOX, SRM, PADI2 | CA1 402/4885CA2 760/4885CA4 930/4885 |
| US-10294210-B2 | Maleinated derivatives | SMOX, SRM, PADI2 | CA1 377/4885CA2 737/4885CA4 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.